Bulletin
Investor Alert

New York Markets Close in:

BioMarin Pharmaceutical Inc.

NAS: BMRN

GO
/marketstate/country/us

Market open

/zigman2/quotes/204560322/composite

$

77.54

Change

+0.96 +1.25%

Volume

Volume 644,475

Sep 25, 2020, 1:30 p.m.

Real time quotes

/zigman2/quotes/204560322/composite

Previous close

$ 76.58

$ 77.54

Change

+0.96 +1.25%

Day low

Day high

$75.84

$77.55

Open
Open: 76.46

52 week low

52 week high

$62.88

$131.95

Open

Market cap

$13.89B

Average volume

2.62M

P/E ratio

116.64

Rev. per Employee

$525,524

EPS

0.66

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bmrn

MarketWatch News on BMRN

  1. How Pfizer Plans to Lead the Industry in Gene Therapies

    10:29 a.m. Sept. 16, 2020

    - Barron's Online

  2. FDA Delays Start of Sarepta’s Gene Therapy Trial

    10:24 a.m. Sept. 10, 2020

    - Barron's Online

  3. Sarepta Therapeutics Stock Is Now a Top Idea at J.P. Morgan

    4:46 p.m. Aug. 25, 2020

    - Barron's Online

  4. BioMarin Stock’s Near-Term Growth Is Gone, Analyst Says

    9:43 a.m. Aug. 20, 2020

    - Barron's Online

  5. Stocks Tiptoe Ahead. News From the Fed Is Next.

    1:22 p.m. Aug. 19, 2020

    - Barron's Online

  6. BioMarin Slumps After FDA Rejects Its Hemophilia Gene Therapy

    12:37 p.m. Aug. 19, 2020

    - Barron's Online

  7. Still waiting for an S&P 500 breakout

    11:32 a.m. July 9, 2020

    - Lawrence G. McMillan

  8. Here’s what to do if the S&P 500 breaks out of its trading range

    10:42 a.m. July 2, 2020

    - Lawrence G. McMillan

  9. Resistance to the stock market’s rally is stiffening

    11:04 a.m. June 25, 2020

    - Lawrence G. McMillan

  10. Neither the stock market’s bulls nor bears can rest easy right now

    12:11 p.m. June 18, 2020

    - Lawrence G. McMillan

  11. BioMarin Pharmaceutical stock price target raised to $143 from $109 at SunTrust RH

    7:05 a.m. June 18, 2020

    - Tomi Kilgore

  12. What Sanofi Might Buy With Its Regeneron Windfall

    10:35 a.m. May 27, 2020

    - Barron's Online

  13. Looking for Yield? You’ll Find it Here.

    9:30 p.m. May 22, 2020

    - Barron's Online

  14. New Convertible-Bond Issues at 12-Year Highs

    4:48 p.m. May 13, 2020

    - Barron's Online

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/bmrn

Other News on BMRN

  1. BioMarin Initiates Gene Therapy Study for Phenylketonuria

    7:53 a.m. Today

    - Zacks.com

  2. Stay Away From These 4 Toxic Stocks to Avoid Losses

    8:48 a.m. Sept. 24, 2020

    - Zacks.com

  3. These 4 Stocks Could Be Toxic for Your Portfolio

    7:01 a.m. Sept. 8, 2020

    - Zacks.com

  4. Top Insider Buys Highlight for the Week of Sept. 4

    1:32 p.m. Sept. 5, 2020

    - GuruFocus.com

  5. BioMarin Pharmaceutical: Appealing After A Pipeline Setback

    12:36 p.m. Aug. 24, 2020

    - Seeking Alpha

  6. BioMarin Down on CRL From FDA for Hemophilia A Candidate

    1:12 p.m. Aug. 20, 2020

    - Zacks.com

  7. Loading more headlines...
/news/pressrelease/company/us/bmrn

Press Releases on BMRN

  1. Non-Small Cell Lung Cancer Market In-deep Analysis And Latest Clinical Advanced Treatment 2020-2026

    6:05 a.m. Today

    - Market Insight Reports

  2. Hemophilia A Treatment Market to witness high growth in near future

    12:26 p.m. Sept. 22, 2020

    - Market Insight Reports

  3. BioMarin to Participate in Four Upcoming Virtual Investor Conferences

    8:30 a.m. Sept. 15, 2020

    - PR Newswire - PRF

  4. Hemophilia Market is Forecasted to Surpass US$17 Billion by 2027

    6:45 a.m. Sept. 15, 2020

    - Global QYResearch

  5. Opthea Appoints US-Based Non-Executive Director

    12:09 p.m. Sept. 10, 2020

    - GlobeNewswire

  6. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.